MedTrace Logo

YKL-40 and IL-6 Levels in Periodontal Disease

NCT03507868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2018-04-25

No results posted yet for this study

Summary

The primer aim of the study was to investigate saliva and gingival crevicular fluid (GCF) YKL-40 and also interleukin-6 (IL-6) levels in chronic periodontitis pathogenesis.

Conditions

  • Periodontal Diseases

Interventions

PROCEDURE

Nonsurgical periodontal therapy

Nonsurgical periodontal therapy includes oral hygiene education and scaling and root planning approaches to eliminate microbial dental plaque that is the primary etiology of periodontal diseases.

Sponsors & Collaborators

  • Zeynep Pinar KELES

    lead OTHER

Eligibility

Min Age
26 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-04-30
Completion
2018-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507868 on ClinicalTrials.gov